BD and BioMedomics Launch Rapid Serology Test to Detect Exposure to COVID-19 in 15 Minutes
Shots:
- BioMedomic develops and manufactures the POC tests that will be available through BD and distributed exclusively by Henry Schein to the HCPs in the US
- The POC test detects Abs in the blood to confirm current or past exposure to COVID-19. The test has been clinically validated at several hospitals and clinical laboratories in both the US and China
- The test is completed in four- simple steps. First- blood is collected via blood collection devices like BD Microtainer Contact-Activated Lancet. A few drops of blood are then transferred to the test cartridge- followed by 2-3 drops of a buffer- with its expected result in 15mins showing multiple lines for positive results and a single line for negative results
Click here to read full press release/ article | Ref: BD | Image: BD
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com